Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Antisense oligonucleotide to ICAM-1 ameliorates chronic intestinal inflammation in transgenic rats

Oct. 21, 2002

GSK researchers identify novel inhibitors of TGF-beta type I (ALK5) receptor

Oct. 17, 2002

InterMune and Inhale to develop PEGylated Infergen

Oct. 16, 2002

Inhibitors of TGF-beta signaling pathway described in GSK patent

Oct. 14, 2002

Phosphonate nucleotide and its oral prodrug with potent, selective anti-HBV activity

Oct. 11, 2002

Ulcerative colitis drug TC-2403-12 completes phase I

Oct. 10, 2002

Small-molecule HCV therapeutics sought in Enanta-Chiron collaboration

Oct. 7, 2002

Novel inhibitors of HCV NS3 protease in BMS pipeline

Oct. 4, 2002

InterMune and Array BioPharma collaborate on hepatitis drug discovery

Oct. 2, 2002

Clinical efficacy and safety of ACH-126443 in HBV demonstrated in phase I/II clinical trial

Oct. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...